6814 logo

Lukas Biomedical Inc. Stock Price

TPEX:6814 Community·NT$929.6m Market Cap
  • 0 Narratives written by author
  • 0 Comments on narratives written by author
  • 0 Fair Values set on narratives written by author

6814 Share Price Performance

NT$0
-24.90 (-100.00%)
NT$0
-24.90 (-100.00%)
Price NT$0

6814 Community Narratives

There are no narratives available yet.

Trending Discussion

Updated Narratives

No recently updated narratives available.

Snowflake Analysis

Low risk with imperfect balance sheet.

3 Risks
0 Rewards

Lukas Biomedical Inc. Key Details

NT$179.5m

Revenue

NT$71.6m

Cost of Revenue

NT$107.9m

Gross Profit

NT$193.5m

Other Expenses

-NT$85.6m

Earnings

Last Reported Earnings
Dec 31, 2025
Next Reporting Earnings
n/a
-2.04
60.10%
-47.71%
51.4%
View Full Analysis

About 6814

Founded
2002
Employees
87
CEO
Chaoan Liu
WebsiteView website
www.lukas-biomedical.com

Lukas Biomedical Inc. engages in the wholesale and retail of cosmetics in Taiwan. The company operates through E-Commerce Department, Medical Management Business, Cell Products Department, and Pharmaceutical Market Development Department segments. It also researches and develops immune cell medical technology for regenerative medicine and adjuvant treatment; engages in clinical trials; distributes immune cell therapy culture technology; and leases building equipment. In addition, the company involved in the new immune cell research and development, new product development, clinical trials, and production of cell reagents; and provision of brand management and medical management services. Lukas Biomedical Inc. was founded in 2002 and is based in New Taipei City, Taiwan.

Recent 6814 News & Updates

Recent updates

No updates